With about one in eight women experiencing postpartum depression, amid a shortage of mental health providers, researchers at the University of Texas are looking to bridge the gap with an AI chatbot.
The AI chatbot’s algorithm is trained to handle common postpartum questions and issues such as trouble with personal connections and breastfeeding challenges.
The Food and Drug Administration has approved Zurzuvae, a new, fast-acting drug designed to treat postpartum depression. Experts explain the drug and how it helps new parents with postpartum depression.